Gender difference in the miotic potency of soman vapor in rats

Cutaneous and Ocular Toxicology

Volumn 27, Issue 2, 2008, Pages 123-133

  Dabisch, Paul A ^a   Horsmon, Michael S ^a   Taylor, James T ^b   Muse, William T ^a   Miller, Dennis B ^a   Sommerville, Douglas R ^a   Mioduszewski, Robert J ^a   Thomson, Sandra ^a  

^a EDGEWOOD CHEMICAL BIOLOGICAL CENTER   (United States)

^b NATIONAL RESEARCH COUNCIL   (United States)

Author keywords

Acetylcholinesterase; Butyrylcholinesterase; Gender differences; Miosis; Nerve agent; Potency comparison; Pupil constriction; Soman

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; CYCLOSARIN; SARIN; SOMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MALE; MIOSIS; NONHUMAN; PUPILLOGRAPHY; RAT; SENSITIVITY ANALYSIS; SEX DIFFERENCE; VAPOR;

ACETYLCHOLINESTERASE; ANALYSIS OF VARIANCE; ANIMALS; BUTYRYLCHOLINESTERASE; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; EYE; FEMALE; INFRARED RAYS; MALE; MIOSIS; MODELS, ANIMAL; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTHIOPHOSPHORUS COMPOUNDS; PUPIL; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS; SOMAN;

RATTUS;

EID: 45849120940     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.1080/15569520802064376     Document Type: Article

References (26)

1. Sim VM. Effect on Pupil Size of Exposure to GB Vapour, Directorate of Chemical Defence Research and Development-Porton Technical Paper #531, DTIC# AD 092597; Washington, DC: 1956.
2. U.S. Army. United States Army Field Manual (FM) 3-11.9. Potential military chemical/biological agents and compounds; Washington, DC: U.S. Army. 2005.
3. Masuda N, Takatsu M, Morinari H, Ozawa T. Sarin poisoning in Tokyo subway. Lancet 1995; 345:1446.
4. Nozaki H, Hori S, Shinozawa Y, Fujishima S, Takuma K, Kimura H, Suzuki M, Aikawa N. Relationship between pupil size and acetylcholinesterase activity in patients exposed to sarin vapor. Intensive Care Med 1997; 23:1005-1007.
5. Yanagisawa N, Morita H, Nakajima T. Sarin experiences in Japan: acute toxicity and long-term effects. J Neurol Sci 2006; 249:76-85.
6. Benton BJ, Sommerville DR, Scotto J, Burnett DC, Gaviola BI, Crosier RB, Jakubowski EM, Whalley CE, Anthony JS, Hulet SW, Dabisch PA, Reutter SA, Forster JS, Mioduszewski RJ, Thomson SA, Matson KL, Crouse CL, Miller DB, Evans RA, McGuire JM, Jarvis JR. Low-Level Effects of VX Vapor Exposure on Pupil Size and Cholinesterase Levels in Rats, U.S. Army ECBC Technical Report TR-428, DTIC#ADA432945; Washington, DC: 2005.
7. Whalley CE, Benton BJ, Manthei JH, Way RA, Jakubowski EM, Burnett DC, Gaviola BI, Crosier RB, Sommerville DR, Muse WT, Forster JS, Mioduszewski RJ, Thomson SA, Scotto JA, Miller DB, Crouse CL, Matson KL, Edwards JL. Low-Level Cyclosarin (GF) Vapor Exposure in Rats: Effect of Exposure Concentration and Duration on Pupil Size, U.S. Army ECBC Technical Report TR-407, DTIC # ADA429234; Washington, DC: 2004.
8. Hulet SW, Sommerville DR, Crosier RB, Dabisch PA, Miller DB, Benton BJ, Forster JS, Scotto JA, Jarvis JR, Krauthauser C, Muse WT, Reutter SA, Mioduszewski RJ, Thomson SA. Comparison of low-level sarin and cyclosarin vapor exposure on pupil size of the Gottingen minipig: Effects of exposure and duration. Inhal Toxicol 2006; 18:143-153.
9. Dabisch PA, Horsmon MS, Muse WT, Mioduszewski RJ, Thomson SA. Muscarinic receptor dysfunction induced by exposure to low-levels of soman vapor. Toxicol Sci 2007; 100:281-289.
10. Henderer JD, Rapuano JD. Ocular pharmacology. In: Limbird LE, Hardman JG, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed.; New York: McGraw-Hill Medical Publishing Division. 2006:1707-1737.
11. Bergamin O, Zimmerman MB, Kardon RH. Pupil light reflex in normal and diseased eyes: diagnosis of visual dysfunction using waveform partitioning. Ophthalmology 2003; 110:106-114.
12. Lee I, Choi B, Park KW, Kim SS, Hwang JM. Development of pupillography using image processing. Korean J Ophthalmol 2005; 19:149-152.
13. Yasukouchi A, Hazama T, Kozaki T. Variations in the light-induced suppression of nocturnal melatonin with special reference to variations in the pupillary light reflex in humans. J Physiol Anthropol 2007; 26:113-121.
14. Dabisch PA, Miller DB, Burnett DC, Jakubowski EM, Muse WT, Forster JS, Davis EA, Jarvis JR, Scotto JA, Hulet SW, Reutter SA, Mioduszewski RJ, Thomson SA. Tolerance to the miotic effect of sarin vapor following multiple low-level exposures. J Ocul Pharmacol Ther 2005; 21:182-195.
15. Furuta M, Ohya S, Imaizumi Y, Watanabe M. Molecular cloning of m3 muscarinic acetylcholine receptor in rat iris. J Smooth Muscle Res 1998; 34:111-122.
16. Smith RD, Grzelak ME, Belanger B, Morgan CA. The effects of tropicamide on mydriasis in young rats exhibiting a natural deficit in passive-avoidance responding. Life Sci 1996; 59:753-760.
17. 1A-Adrenoceptors mediate sympathetically evoked pupillary dilation in rats. J Pharmacol Exp Ther 2002; 300:521-525.
18. Yu Y, Koss MC. Functional characterization of alpha-adrenoceptors mediating pupillary dilation in rats. 2003; 471:135-140.
19. Institute of Laboratory Animal Resources, Commission of Life Sciences, National Research Council. Guide for the Care and Use of Laboratory Animals; Washington, DC: National Academy Press. 1996.
20. Muse WT, Thomson S, Crouse C, Matson K. Generation, sampling, and analysis for low-level GB (sarin) and GF (cyclosarin) vapor for inhalation toxicology studies. Inhal Toxicol 2006; 18:1101-1108.
21. Bliss CI. The method of probits. Science 1934; 79:38-39.
22. Bliss CI. The calculation of the dosage-mortality curve. Ann Appl Biol 1935; 22:134-167.
23. Bliss CI. The calculation of the time-mortality curve. Ann Appl Biol 1937; 24:815-852.
24. Bliss CI. The Statistics of Bioassay with Special References to the Vitamins; New York, NY: Academic Press Inc. 1952.
25. Finney DJ. Probit Analysis. 3rd ed.; Cambridge, UK: Cambridge University Press. 1971.
26. Dutsch M, Marthol H, Michelson G, Neundorfer B, Hilz MJ. Pupillography refines the diagnosis of diabetic autonomic neuropathy. J Neurol Sci 2004; 222:75-81.